14 results
Chart of Inhalers for Asthma and COPD
 - SABA - Short Acting Beta-2 Agonists
 - SAMA
-2 Agonists - LAMA ... Antagonists - LAMA ... - ICS + LAMA + ... #asthma #copd #respiratory ... #pharmacology #
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
Pharmacologic treatment ... long-acting β2-agonist; ICS ... ; FEV1: forced expiratory ... #Management #Pulmonary ... #LABA #ICS #Guidelines
Asthma Maintenance Therapy - Stepwise Approach 

Low dose ICS 
-> Low dose ICS/LABA or Med/High dose
dose ICS/LABA ... (LAMA) can be added ... nonpharmacologic management ... Stepwise #Therapy #Management ... #Pharmacology #
Medical Treatment Algorithm for Chronic Obstructive Pulmonary Disease
Initial medical treatment of chronic obstructive pulmonary disease (COPD)
; FEV1, forced expiratory ... of expiration; ICS ... long-acting β2-agonist; LAMA ... Treatment #Algorithm #Management ... #ICS #Pharmacology
COPD Preferred Treatments - GOLD 2018 

COPD is a common progressive respiratory condition that can be
common progressive respiratory ... Management of COPD ... anticholinergics) and ICS ... LAMA/LABA/ICS. ... COPD #Treatment #Management
The 2019 Global Initiative for Asthma (GINA) treatment strategy figure for adults and adolescents, annotated to
ICS: inhaled corticosteroids ... receptor antagonists; LABA ... long-acting β2-agonists; OCS ... ; FEV1: forced expiratory ... #GINA #Asthma #Management
First-line therapies for Asthma, Asthma-COPD Overlap and COPD

The diagnosis of COPD, asthma, and ACO initially requires
of exposure to respiratory ... and pattern of respiratory ... asthma-COPD overlap; ICS ... long-acting β2-agonist; LAMA ... #Diagnosis #Management
Opioid Overdose Management and Discharge Criteria

Patients with presumed opioid overdose were safely discharged one hour after
Opioid Overdose Management ... air of >92% 3) Respiratory ... beats/min 6) GCS ... Opioid #Overdose #Management ... Criteria #Opiate #Narcan
Naloxone - Toxicology

Adult starting dose:
 - 0.4 mg IV/IM/IO/SQ for non-opioid dependent patients
 - 0.04 mg
If an infusion is ... that improved respiratory ... #Naloxone #Narcan ... #Toxicology #Management ... #Pharmacology #
Myasthenia Gravis Overview

Myasthenia Gravis is an autoimmune disorder of the postsynaptic neuromuscular junction.  Ab to
Myasthenia Gravis is ... Respiratory muscles ... Respiratory insufficiency ... immunosuppressants - Meds ... Gravis #diagnosis #management